Abbasi, Salah, et al. “A Pilot Study of Activity of Pembrolizumab and Low Dose Chemotherapy in Relapsed Refractory T-Cell Lymphoma: Jordanian Experience”. Acta Biomedica Atenei Parmensis, vol. 95, no. 5, Oct. 2024, p. e2024102, https://doi.org/10.23750/abm.v95i5.15559.